Funding and fundraising are key for biotechnology companies to bring their innovations to life, to contribute to breakthroughs and save lives. However, research and development is a costly process and numerous are the companies which are halted at different stages of their business life cycle. This is particularly challenging for startups or small companies which have high operating costs and little to no revenues.
Below is a non-exhaustive list on fundraising opportunities:
- Government grants: governments can offer significant funding sources based on how well your research stage fits the grant proposal. Bear in mind this is a highly competitive process and you should expect multiple submission rounds, audit requirements and interview processes. These grants vary by country and stage (discovery, development and commercialization), so look out for the applications windows and deadlines. Some grant application tips include scientific merit (explain in layman and scientific terms the science behind your idea) and eligibility (make sure your research/idea fits with the grant criteria for example that your proposed timescale aligns with the funding time).
- Non-government grants: government grants have the caveat of being limiting (having to use funding on specific aspects), highly competitive (low success rate) and onerous validation process (audits can be expensive). Non-governmental grants can be delivered by charities, agencies, family foundations, corporate foundations. Partnering with corporate firms will allow you to have one foot in the industry which may facilitate future rounds of fundraising and commercialisation later on.
- Incubators and accelerators: provide early stage support desperately needed for startups. Incubators cuts operational costs, gain mentorship support and develop business exposure. Accelerators on the other hand, will be useful to more advanced startups with a minimally viable product (MVP). A MVP is characterized with enough features to attract early-adopter customers and used to validate an idea in the product development cycle.
Featured Courses
The CPD accredited courses are carefully crafted to help you gain in-depth knowledge on a topic of your interest.
Stem Cell Technology
The field of stem cell technology is a cornerstone of regenerative medicine, offering transformative pathways to repair or replace damaged tissues. This course provides a comprehensive exploration of stem cell biology, from the fundamental differences in cell potency to advanced techniques such as induced pluripotency and direct reprogramming. Participants will gain insight into differentiation protocols, the development of 3D organoid systems, and the application of CRISPR gene editing to correct disease-associated mutations. Beyond the laboratory, the course addresses essential quality control standards, global regulatory frameworks, and the complex ethical landscape of modern biotechnology.
Next Generation Sequencing (NGS)
This intermediate-level course provides a thorough overview of the field of next-generation sequencing, from its properties and strength and its major applications, to an overview of a typical sequencing workflow.
Molecular Ageing
The study of molecular ageing is a cutting-edge discipline, providing a novel lens through which to understand and treat age-related decline. This course offers a comprehensive introduction to the biological drivers of ageing, from evolutionary theories to the molecular hallmarks that define the biological clock. Participants will explore the mechanisms of DNA repair, the impact of oxidative stress, and emerging therapeutic frontiers, including senolytics and rejuvenation technologies moving from the laboratory into clinical consideration.
Cancer Biology: Exploring the Molecular and Genetic Aspects
This is an intermediate-level course that explores the molecular and genetic basis of cancer, its evolution, and cancer immunology.
Neuroscience
Neuroscience is one of the most advanced and fastest growing sciences. The beginning of the 21st century has seen huge developments in techniques to study and understand how the brain works.
CRISPR: Revolutionising Genome Editing
This advanced-level course is designed to develop an understanding of complex concepts related to genomics, particularly CRISPR/Cas technology and its applications...
4. Private investment: this is particularly useful to medicine/clinical based companies who are racing the clock to not lose a competitive advantage over other startups. To maximise your chances of attracting investors, you should network by giving and attending presentations at industry conferences. What better way to learn more about the industry, understand any competition and meet future investors? Corporate companies such as Pfizer, AstraZeneca and Novo Nordisk also invest in biotech startups so look out for opportunities.
5. Partner with pharmaceutical companies: multinational pharmaceutical companies spend substantial amounts on research and development (R&D) to ensure that their products and services remain cutting-edge. To maintain their competitive advantage, they often turn to startups for novel ideas and innovations in the field. For example, you may collaborate on clinical trials and have access to their resources (labs, supplies, resources). However, everything comes with a cost and you may lose some intellectual property (IP) rights.
